How Does Bleeding Stop Without Blocking Everything? A System on a Knife Edge

Damage to a vessel exposes material that is normally hidden behind the smooth lining, and that exposure starts everything. Platelets, small cell fragments circulating in enormous numbers, stick to the exposed surface and to each other, forming a temporary plug within seconds. The vessel constricts, reducing flow. A cascade of proteins circulating in an inactive form is then triggered, each activating the next, ending in the conversion of a soluble protein into insoluble fibres that form a mesh through and around the platelet plug. That mesh traps red cells and converts the temporary plug into a stable structure. The whole sequence is amplified at each stage, so a small trigger produces a large and rapid response.

The length of the sequence looks wasteful and does specific work:

• •Each step multiplies the signal, so a tiny trigger produces a rapid response
• •Multiple steps give multiple points at which the process can be regulated
• •Several of the proteins require a surface to act on, confining the reaction to the damage
• •Calcium and vitamin K dependent modifications are needed, which adds further control
• •Natural inhibitors circulate continuously, switching the process off away from the injury
• •Separate pathways converge, so the system has redundancy

Containing the response is as important as producing it, and several mechanisms do that work simultaneously. The healthy vessel lining actively resists platelet attachment and produces substances that keep them from aggregating, so the reaction stops at the edge of the damage. Circulating inhibitors neutralise the activated proteins continuously, and a deficiency in any of them causes a lifelong tendency to clot inappropriately. Flowing blood dilutes and carries away activated factors, which is why stagnant blood clots and moving blood does not, and why immobility is a major risk. A separate system dissolves the mesh once the vessel has healed, converting another circulating protein into an enzyme that breaks the fibres down. Drugs that trigger that system are used to treat strokes and heart attacks.

The visible crust on a cut and the structure inside a vessel are related and worth distinguishing. A scab forms where the mesh is exposed to air, dries out and hardens, and it serves as a temporary physical cover under which the skin repairs itself. Underneath it, cells migrate across the gap, divide and rebuild the layers, and the crust detaches once that is complete. Picking it off removes the cover and the partly rebuilt tissue with it, which is why it delays healing and worsens scarring. A clot inside a vessel never dries, stays soft, and is removed by the dissolving system rather than by falling off. The material is essentially the same in both cases and only the location and the fate differ.

Failure in either direction is serious and the two categories are treated very differently. Too little clotting produces bleeding disorders, of which haemophilia is the best known, caused by a missing factor in the cascade and treated by supplying it. Liver disease causes bleeding because the factors are made there. Too much clotting is by far the more common problem in developed countries, producing clots in leg veins that can travel to the lungs, and clots on damaged artery walls that cause heart attacks and most strokes. Risk rises with immobility, surgery, pregnancy, some hormonal medication, cancer and inherited variants. Anticoagulant drugs reduce that risk and increase bleeding risk, which is a trade-off managed individually rather than a problem with a clean solution.

Damage exposes material that platelets stick to, and an amplifying cascade of proteins converts a soluble protein into a fibre mesh that stabilises the plug. The many steps exist to amplify, to localise and to allow regulation. Healthy vessel lining, circulating inhibitors and flowing blood keep the reaction at the wound, and failure in either direction causes bleeding disorders or dangerous clots.